Skip to content

Exelixis EXEL Other Income (Expense)

Other Income (Expense) at other companies

Eli Lilly logo
Eli LillyLLY
-$65M+72.8%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$5.79M+47.0%
Incyte logo
IncyteINCY
$2.77M-65.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$456K-198%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$60.6M+7.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$53.4M+700%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's other income (expense)?
Exelixis (EXEL) reported other income (expense) of $219K in Q1 2026.
How has Exelixis's other income (expense) changed year-over-year?
Exelixis's other income (expense) increased by 189.4% year-over-year, from -$245K to $219K.
What does other income (expense) mean?
Miscellaneous income or expenses not related to the core business.
How do you interpret other income (expense)?
Large fluctuations may indicate non-recurring events or volatility in foreign currency markets.
How does other income (expense) compare across companies?
Standard line item in income statements across all industries.